Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network

This retrospective single-arm study assessed real-world treatment patterns and clinical outcomes in patients with hormone receptor—positive/human epidermal growth factor receptor 2—negative (HR+/HER2−) advanced/metastatic breast cancer (A/MBC) who received palbociclib plus an aromatase inhibitor as...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Jeanna Wallenta, Mitra, Debanjali, Kaplan, Henry G., Alfred, Tamuno, Brufsky, Adam M., Emir, Birol, McCracken, Haley, Liu, Xianchen, Broome, Ronda G., Zhang, Chenan, DiCristo, Caroline, Chen, Connie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871271/
https://www.ncbi.nlm.nih.gov/pubmed/35200588
http://dx.doi.org/10.3390/curroncol29020089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871271/
https://www.ncbi.nlm.nih.gov/pubmed/35200588
http://dx.doi.org/10.3390/curroncol29020089

Ejemplares similares